Showing results for "Ten" in Medicine & Health Care Industry

Beginning with opium, the “joy plant,” which has been used for 10,000 years, Thomas Hager tells a captivating story of medicine. His subjects include the largely forgotten female pioneer who introduced smallpox inoculation to Britain, the infamous knockout drops, the first antibiotic, which saved countless lives, the first antipsychotic, which helped empty public mental hospitals, Viagra, statins, and the new frontier of monoclonal antibodies. This is a deep, wide-ranging, and wildly entertaining book.

Is your healthcare organization spending too much time on strategy—with too little to show for it? If you read (or listen to) nothing else on strategy, listen to these ten articles. We've combed through hundreds of Harvard Business Review articles and selected the most important ones for healthcare professionals to help you catalyze your organization's strategy development and execution.

Go from being a good practitioner to being an extraordinary leader of healthcare professionals.

Marty, age 57, was given a preliminary diagnosis of ALS by his family doctor. Seven weeks later, the diagnosis was confirmed by a neurologist. Ten months and ten days later, Marty passed away. From day one, Alison, Marty’s spouse of over twenty-five years, kept a journal as a way to navigate the overwhelming state of her mind and soul. Soon the rawness of her words harmonized to tell the story of Marty’s diagnosis, illness, and decline. Dance Me to the End is an evocative memoir about witnessing a loved one suffer from a neurological, degenerative, and terminal disease.

The Coming Healthcare Revolution identifies and describes five top-down macro forces and five bottom-up market forces that have sufficient strength to transform the US healthcare industry from the outside-in. The powerful macro forces are demographic determinants, funding fatigue, chronic pandemics, technological imperatives, and pro-consumer/market reforms.

Pharma Customer Experience reveals twenty secrets that pharmaceutical and biotechnology companies are using today to connect emotionally with their customers—both patients and healthcare professionals.